Freeze drying

Freeze drying appears to be the most secure and fastest technique to market biomolecular drugs. Due to undercapacity, producing freeze dried drugs requires massive investment.
Thanks to 2 sites located in France and Spain, specialised in freeze dried sterile and non sterile drugs, Synerlab recently invested 5 million euro to increase caapcity. As of 2018, the French site have been approved to produce sterile freeze dried injectable cytotoxic for human consumption and experimental ventures.
The value proposition generated through two sites specialized in freeze drying is unique, from manufacturing process optimization to producing freeze dried characterized and documented vials, allowing their clients to differentiate on their own markets.